Biostate
Phase 3Completed 0 watching 0 views this week📈 Rising
76
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Von Willebrand Disease
Conditions
Von Willebrand Disease
Trial Timeline
Aug 1, 2010 → Aug 1, 2013
NCT ID
NCT01213446About Biostate
Biostate is a phase 3 stage product being developed by CSL for Von Willebrand Disease. The current trial status is completed. This product is registered under clinical trial identifier NCT01213446. Target conditions include Von Willebrand Disease.
Hype Score Breakdown
Clinical
27
Activity
18
Company
9
Novelty
9
Community
10
Clinical Trials (4)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01445197 | Phase 3 | Terminated |
| NCT01224808 | Phase 3 | Completed |
| NCT01229007 | Phase 3 | Completed |
| NCT01213446 | Phase 3 | Completed |
Competing Products
14 competing products in Von Willebrand Disease
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| Von Willebrand Factor Concentrates + Von Willebrand Factor Concentrates and Factor VIII Concentrates + Factor VIII Concentrates + Recombinant Activated Factor VII + Activated Prothrombin Complex Concentrate | Roche | Pre-clinical | 23 |
| Emicizumab + von Willebrand Factor (VWF) Concentrates + Factor VIII (FVIII) Concentrates + von Willebrand Factor (VWF) and Factor VIII (FVIII) Concentrates + Bypassing Agents | Roche | Phase 3 | 77 |
| Neumega (Oprelvekin, Interleukin 11, IL-11) | Pfizer | Phase 2 | 51 |
| Oprelvekin, Interleukin 11, IL-11 | Pfizer | Phase 2 | 51 |
| recombinant interleukin-11 + recombinant interleukin-11 + recombinant interleukin-11 | Pfizer | Phase 2 | 51 |
| efanesoctocog alfa (BIVV001) | Sanofi | Phase 1 | 32 |
| Biostate | CSL | Phase 3 | 76 |
| Voncento® | CSL | Pre-clinical | 22 |
| Blood coagulation Factor VIII and vWF, human | CSL | Approved | 84 |
| Biostate® + Biostate® | CSL | Phase 2/3 | 64 |
| VWF/FVIII products | CSL | Pre-clinical | 22 |
| Voncento | CSL | Approved | 84 |
| Alphanate SD/HT | Grifols | Approved | 82 |
| plasma-derived FVIII/VWF concentrate | Grifols | Approved | 82 |